Skip to content

Unethical companies are finding desperate patients who are willing to pay big money for unproven stem cell "treatments." This may harm not only patients, but stem cell research itself.

Unethical companies are finding desperate patients who are willing to pay big money for unproven stem cell "treatments." This may harm not only patients, but stem cell research itself.